GlaxoSmithKline

$40.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.43 (1.07%) Today
+$0.13 (0.32%) As of 7:00 AM EDT after-hours

Why Robinhood?

You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!

About GSK

GlaxoSmithKline plc, also called GlaxoSmithKline, is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. Read More The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Employees
95,490
Headquarters
Brentford, Greater London
Founded
1999
Market Cap
92.66B
Price-Earnings Ratio
17.49
Dividend Yield
5.40
Average Volume
2.08M
High Today
$40.88
Low Today
$40.58
Open Price
$40.69
Volume
1.93M
52 Week High
$42.47
52 Week Low
$36.41

Collections

GSK News

Reuters58m

GSK's long acting HIV injection gets boost from study

0
MarketWatch4h

GlaxoSmithKline ViiV reports positive HIV study

0
Reuters5h

GSK new HIV two-drug injection meets main goal in late-stage study

0

GSK Earnings

$0.34
$0.52
$0.70
$0.88
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Available Oct 30

Popular Stocks

More GSK News

ReutersAug 14

AstraZeneca scores win in race to treat ovarian cancer

215
ReutersAug 3

Edited Transcript of GSK.L earnings conference call or presentation 24-Jul-19 1:00pm GMT

16
ReutersJul 25

GSK wins access to records on researcher's link to Zofran plaintiffs' lawyers

41
BloombergJul 25

Astra, Roche Join Rivals in Boosting Forecasts as New Drugs Prosper

32
ReutersJul 24

WRAPUP 1-GSK raises 2019 earnings expectations after standout quarter for Shingrix

71
MarketWatchJul 24

GlaxoSmithKline's revenue boosted by vaccines

76
Wall Street JournalJul 24

GlaxoSmithKline’s Vaccines Boost Its Revenue, Inoculate It From Advair Rivals

11
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.